KR20040081492A - 아실아미노알케닐렌-아미드 유도체의 기능성 내장 운동장애에 있어서의 용도 - Google Patents

아실아미노알케닐렌-아미드 유도체의 기능성 내장 운동장애에 있어서의 용도 Download PDF

Info

Publication number
KR20040081492A
KR20040081492A KR10-2004-7012191A KR20047012191A KR20040081492A KR 20040081492 A KR20040081492 A KR 20040081492A KR 20047012191 A KR20047012191 A KR 20047012191A KR 20040081492 A KR20040081492 A KR 20040081492A
Authority
KR
South Korea
Prior art keywords
phenyl
hydrogen
methyl
formula
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR10-2004-7012191A
Other languages
English (en)
Korean (ko)
Inventor
존 알. 포자드
에크하르트 베버
한스-위르겐 판쿠헤
Original Assignee
노파르티스 아게
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 노파르티스 아게 filed Critical 노파르티스 아게
Publication of KR20040081492A publication Critical patent/KR20040081492A/ko
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Nutrition Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
KR10-2004-7012191A 2002-02-08 2003-02-07 아실아미노알케닐렌-아미드 유도체의 기능성 내장 운동장애에 있어서의 용도 Ceased KR20040081492A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0203061.7 2002-02-08
GBGB0203061.7A GB0203061D0 (en) 2002-02-08 2002-02-08 Organic compounds
PCT/EP2003/001227 WO2003066062A1 (en) 2002-02-08 2003-02-07 Use of acylaminoalkenylene-amide derivatives in functional motility disorders of the viscera

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020107017008A Division KR20100100994A (ko) 2002-02-08 2003-02-07 아실아미노알케닐렌-아미드 유도체의 기능성 내장 운동 장애에 있어서의 용도

Publications (1)

Publication Number Publication Date
KR20040081492A true KR20040081492A (ko) 2004-09-21

Family

ID=9930743

Family Applications (2)

Application Number Title Priority Date Filing Date
KR10-2004-7012191A Ceased KR20040081492A (ko) 2002-02-08 2003-02-07 아실아미노알케닐렌-아미드 유도체의 기능성 내장 운동장애에 있어서의 용도
KR1020107017008A Ceased KR20100100994A (ko) 2002-02-08 2003-02-07 아실아미노알케닐렌-아미드 유도체의 기능성 내장 운동 장애에 있어서의 용도

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1020107017008A Ceased KR20100100994A (ko) 2002-02-08 2003-02-07 아실아미노알케닐렌-아미드 유도체의 기능성 내장 운동 장애에 있어서의 용도

Country Status (18)

Country Link
US (2) US20050203164A1 (cg-RX-API-DMAC10.html)
EP (2) EP1476167A1 (cg-RX-API-DMAC10.html)
JP (2) JP2005516994A (cg-RX-API-DMAC10.html)
KR (2) KR20040081492A (cg-RX-API-DMAC10.html)
CN (1) CN1301714C (cg-RX-API-DMAC10.html)
AU (1) AU2003244446B2 (cg-RX-API-DMAC10.html)
BR (1) BR0307479A (cg-RX-API-DMAC10.html)
CA (1) CA2471964A1 (cg-RX-API-DMAC10.html)
GB (1) GB0203061D0 (cg-RX-API-DMAC10.html)
IL (2) IL162816A0 (cg-RX-API-DMAC10.html)
MX (1) MXPA04007640A (cg-RX-API-DMAC10.html)
NO (1) NO20043735L (cg-RX-API-DMAC10.html)
NZ (1) NZ534231A (cg-RX-API-DMAC10.html)
PL (1) PL370255A1 (cg-RX-API-DMAC10.html)
RU (1) RU2353356C2 (cg-RX-API-DMAC10.html)
TW (1) TWI330177B (cg-RX-API-DMAC10.html)
WO (1) WO2003066062A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA200404960B (cg-RX-API-DMAC10.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0203061D0 (en) * 2002-02-08 2002-03-27 Novartis Ag Organic compounds
AU2004283038B9 (en) * 2003-10-27 2008-04-24 Novartis Ag Use of neurokinin antagonists in the treatment of urinary incontinence
JP2010502736A (ja) 2006-09-08 2010-01-28 オレ・ファーマシューティカルズ・インコーポレーテッド 消化管の炎症を低減または軽減するための方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5217996A (en) * 1992-01-22 1993-06-08 Ciba-Geigy Corporation Biaryl substituted 4-amino-butyric acid amides
US5457101A (en) * 1994-06-03 1995-10-10 Eli Lilly And Company Thieno[1,5]benzoidiazepine use
DE69602087T2 (de) * 1995-02-22 1999-09-09 Novartis Ag 1-aryl-2-acylamino-ethan-verbindungen und ihre verwendung als neurokinin- insbesondere als neurokinin-1-antagonisten
CR5278A (es) * 1995-03-24 1996-07-04 Lilly Co Eli Formulacion oral de 2-metil-tieno-benzodiacepina
GB9525296D0 (en) * 1995-12-11 1996-02-07 Merck Sharp & Dohme Therapeutic agents
MY132550A (en) * 1996-08-22 2007-10-31 Novartis Ag Acylaminoalkenylene-amide derivatives as nk1 and nk2 antogonists
GB9708484D0 (en) * 1997-04-25 1997-06-18 Merck Sharp & Dohme Therapeutic agents
PL191496B1 (pl) * 1997-07-02 2006-05-31 Merck & Co Inc Odmiana polimorficzna 2-(R)-{1-(R) -[3,5-bis(trifluorometylo)-fenylo]etoksy} -3-(S)-(4-fluoro) fenylo-4-[3-(5-okso-1H,4H-1,2,4-triazolo)metylo] morfoliny, sposób jej wytwarzania, zawierająca ją kompozycja farmaceutyczna i jej zastosowanie
TW520370B (en) * 1998-11-20 2003-02-11 Meiji Seika Kaisha Benzooxazole derivatives and a pharmaceutical composition containing the derivatives as an active ingredient
RU2161894C1 (ru) * 1999-08-10 2001-01-20 НИФ "Ультрасан" Лечебно-профилактическая композиция
GB0010958D0 (en) 2000-05-05 2000-06-28 Novartis Ag Organic compounds
CA2432543A1 (en) * 2000-12-22 2002-07-04 Takeda Chemical Industries, Ltd. Combination drugs
GB0203061D0 (en) * 2002-02-08 2002-03-27 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
US20070293473A1 (en) 2007-12-20
JP2010241835A (ja) 2010-10-28
CA2471964A1 (en) 2003-08-14
NZ534231A (en) 2007-02-23
BR0307479A (pt) 2004-12-07
CN1301714C (zh) 2007-02-28
TW200302818A (en) 2003-08-16
HK1077749A1 (en) 2006-02-24
KR20100100994A (ko) 2010-09-15
IL162816A (en) 2010-11-30
US20050203164A1 (en) 2005-09-15
AU2003244446B2 (en) 2006-08-10
PL370255A1 (en) 2005-05-16
ZA200404960B (en) 2006-05-31
EP2216025A3 (en) 2010-11-10
IL162816A0 (en) 2005-11-20
AU2003244446A1 (en) 2003-09-02
EP1476167A1 (en) 2004-11-17
CN1627947A (zh) 2005-06-15
NO20043735L (no) 2004-09-07
JP2005516994A (ja) 2005-06-09
EP2216025A2 (en) 2010-08-11
MXPA04007640A (es) 2004-11-10
WO2003066062A1 (en) 2003-08-14
TWI330177B (en) 2010-09-11
RU2353356C2 (ru) 2009-04-27
RU2004127132A (ru) 2005-06-10
GB0203061D0 (en) 2002-03-27

Similar Documents

Publication Publication Date Title
JP6205133B2 (ja) 抗炎症剤としての恒久的に荷電したナトリウムおよびカルシウムチャンネルブロッカー
CN1065531C (zh) 用作一氧化氮合成酶抑制剂的氨基四唑衍生物
US7226949B2 (en) Compounds of use in the treatment of epilepsy, seizure, and electroconvulsive disorders
KR19990072798A (ko) 척수손상으로인한임포텐스를치료하기위한약학조성물
KR20070065888A (ko) 염증성 장질환을 치료하기 위한(z)-2-시아노-3-하이드록시-부트-2-엔산-(4'-트리플루오로메틸페닐)-아미드의 용도
KR20070029740A (ko) 통증 치료를 위한 레복세틴의 용도
KR20100100994A (ko) 아실아미노알케닐렌-아미드 유도체의 기능성 내장 운동 장애에 있어서의 용도
JP4611308B2 (ja) 鏡像的に純粋な(r)2,3−ベンゾジアゼピンを使用する胃腸の機能不全及び関連するストレスの治療
TW202035415A (zh) 用於治療骨關節炎的化合物
JPH11505243A (ja) Aii受容体アンタゴニストの新規な薬理学的使用
KR20090083891A (ko) S-니트로소티올 화합물 및 관련 유도체
EA007952B1 (ru) Применение ирбесартана для изготовления лекарств, которые пригодны для предупреждения или лечения лёгочной артериальной гипертензии
EP1963277B1 (en) Fluorinated compounds
JP7396991B2 (ja) 癌、潰瘍性大腸炎、及び関連する炎症性疾患の処置に有用な方法、並びにイソインドリン-1,3-ジオン及びイソインドールプロドラッグの組成物
HK1145139A (en) Use of acylaminoalkenylene-amide derivatives in irritable bowel syndrome and functional dyspepsia
WO2002022127A1 (en) Use of phosphodiesterase inhibitors for the treatment of anorectal disorders
RU2700595C1 (ru) Производное 3,6,9-триазатрициклотетрадекана и его применение для лечения депрессии
JP4598674B2 (ja) 統合失調症治療剤
JP2000355551A (ja) 医薬組成物
HK1077749B (en) Use of acylaminoalkenylene-amide derivatives in functional motility disorders of the viscera
JP2007509184A (ja) 尿失禁の処置におけるニューロキニンアンタゴニストの使用
WO2007041506A1 (en) Purine formulations and methods for managing disorders
JP2002114681A (ja) 勃起不全治療剤
WO2005002622A1 (ja) 疼痛閾値低下抑制剤

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20040806

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20080131

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20091118

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20100629

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20091118

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

A107 Divisional application of patent
J201 Request for trial against refusal decision
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20100729

PJ0201 Trial against decision of rejection

Patent event date: 20100729

Comment text: Request for Trial against Decision on Refusal

Patent event code: PJ02012R01D

Patent event date: 20100629

Comment text: Decision to Refuse Application

Patent event code: PJ02011S01I

Appeal kind category: Appeal against decision to decline refusal

Decision date: 20120131

Appeal identifier: 2010101005775

Request date: 20100729

J301 Trial decision

Free format text: TRIAL DECISION FOR APPEAL AGAINST DECISION TO DECLINE REFUSAL REQUESTED 20100729

Effective date: 20120131

PJ1301 Trial decision

Patent event code: PJ13011S01D

Patent event date: 20120201

Comment text: Trial Decision on Objection to Decision on Refusal

Appeal kind category: Appeal against decision to decline refusal

Request date: 20100729

Decision date: 20120131

Appeal identifier: 2010101005775